Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balzarini

Showing results (41-50 of 563) with videos related to

Pageof 57
Sort By:
Biochemical and Biophysical Research Communications|January 31, 1989
Estimation of the lipophilicity of anti-HIV nucleoside analogues by determination of the partition coefficient and retention time on a Lichrospher 60 RP-8 HPLC columnJ Balzarini, M Cools, E De Clercq
Antiviral Research|July 1, 1991
Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivoL Naesens, J Balzarini, E De Clercq
Molecular Pharmacology|June 1, 1991
Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolaseM Cools, J Balzarini, E De Clercq
Nature Medicine|February 14, 1998
Improving AZT efficacyJ Balzarini, B Degrève, E De Clercq
Clinical Chemistry|April 1, 1992
Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detectionL Naesens, J Balzarini, E De Clercq
Gene Therapy|August 6, 1999
Bystander effect of purine nucleoside analogues in HSV-1 tk suicide gene therapy is superior to that of pyrimidine nucleoside analoguesB Degrève, E De Clercq, J Balzarini
Antimicrobial Agents and Chemotherapy|April 1, 1995
Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strainsJ Balzarini, M Baba, E De Clercq
The Journal of Biological Chemistry|March 25, 1993
Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2J Balzarini, C Bohman, E De Clercq
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
SIV/HIV-1 hybrid virus expressing the reverse transcriptase gene of HIV-1 remains sensitive to HIV-1-specific reverse transcriptase inhibitors after passage in rhesus macaquesJ Balzarini, E De Clercq, K Uberla
International Journal of Cancer|August 15, 1990
Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administeredJ Balzarini, L Naesens, E De Clercq
Pageof 57

Showing results (41-50 of 563) with videos related to

Sort By:
Pageof 57
Biochemical and Biophysical Research Communications|January 31, 1989
Estimation of the lipophilicity of anti-HIV nucleoside analogues by determination of the partition coefficient and retention time on a Lichrospher 60 RP-8 HPLC columnJ Balzarini, M Cools, E De Clercq
Antiviral Research|July 1, 1991
Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivoL Naesens, J Balzarini, E De Clercq
Molecular Pharmacology|June 1, 1991
Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolaseM Cools, J Balzarini, E De Clercq
Nature Medicine|February 14, 1998
Improving AZT efficacyJ Balzarini, B Degrève, E De Clercq
Clinical Chemistry|April 1, 1992
Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid chromatography with fluorescence detectionL Naesens, J Balzarini, E De Clercq
Gene Therapy|August 6, 1999
Bystander effect of purine nucleoside analogues in HSV-1 tk suicide gene therapy is superior to that of pyrimidine nucleoside analoguesB Degrève, E De Clercq, J Balzarini
Antimicrobial Agents and Chemotherapy|April 1, 1995
Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strainsJ Balzarini, M Baba, E De Clercq
The Journal of Biological Chemistry|March 25, 1993
Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2J Balzarini, C Bohman, E De Clercq
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
SIV/HIV-1 hybrid virus expressing the reverse transcriptase gene of HIV-1 remains sensitive to HIV-1-specific reverse transcriptase inhibitors after passage in rhesus macaquesJ Balzarini, E De Clercq, K Uberla
International Journal of Cancer|August 15, 1990
Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administeredJ Balzarini, L Naesens, E De Clercq
Pageof 57